Publications for April 2014
Risk, choice and the ‘girl’ vaccine: Unpacking HPV Immunization.
Janice Graham
Health, Risk & Society. , (2012) Vol 14(1): 57-69.Overcoming Liability Concerns in Vaccine Trials Involving Pregnant Women
Chris Kaposy
Accountability in Research , 2012 May;19(3):156-74. doi: 10.1080/08989621.2012.678686Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults
Scott A. Halperin and David Haase
PLoS One , 2011;6(3):e17758. doi: 10.1371/journal.pone.0017758Oseltamivir Pharmacokinetics in Morbid Obesity (OPTIMO Trial).
Shelly McNeil, Todd F. Hatchette and Kathryn L. Slayter
Journal of Antimicrobial Chemotherapy , JAC/dkr257 2083-2091, Sep 2011(In Press)Molecular mimicry between virus and host and its implications for dengue disease pathogenesis.
Robert Anderson
Exp. Biol. Med. , 236, 515-523Interferon-γ stimulates p11-dependent surface expression of annexin A2 in lung epithelial cells to enhance phagocytosis.
Robert Anderson
J. Cell Physiol. , (in press), doi: 10.1002/jcp.23026Endothelial cell surface expression of protein disulfide isomerase activates b1 and b3 integrins and facilitates dengue virus infection.
Robert Anderson
J Cell. Biochem , (in press), doi: 10.1002/jcb.24037RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.
Yan Yan Huang, Sarah McAlpine and Robert Anderson
PLoS One , (in press)Cationic Liposomes Extend the Immunostimulatory Effect of CpG ODN against Burkholderia pseudomallei Infection in BALB/c Mice.
Robert Anderson
Clin Vaccine Immunol , (in press)Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
Chris Richardson and Gary Sisson
PLoS Pathogens , August 2011 Volume 7 Issue 8 e1002240